Unveiling Factors Associated With Older Adult Accrual to Cancer Clinical Trials: Lessons From the ECOG-ACRIN Experience
Journal of the National Comprehensive Cancer Network · 2025
DOI: 10.6004/jnccn.2025.7076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025. Verfasst von Laurie K Pearson und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1University of Massachusetts Chan Medical School, UMass Memorial Medical Center, Worcester, MA. Hauptthemen laut MEDLINE: Neoplasms, Clinical Trials as Topic, Patient Selection. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background: Older adults (OAs) constitute ≥50% of patients with cancer in the United States yet are underrepresented in clinical trials. This study aimed to evaluate the representation of OAs in ECOG-ACRIN (EA) clinical trials and identify factors associated with their participation. Patients and Methods: OA representation was evaluated in landmark EA trials completed between 2005 and 2019 across breast, gastrointestinal, genitourinary, hematologic, and thoracic malignancies. Enrollment was analyzed by age group and compared with age distributions from population-based SEER registries. Each protocol’s eligibility criteria were reviewed for restrictions, such as any history of atrial fibrillation, New York Heart Association Class I–II heart failure, any cancer within 5 years, serum creatinine level exceeding the institutional upper limit of normal, creatinine clearance (CrCl)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1University of Massachusetts Chan Medical School, UMass Memorial Medical Center, Worcester, MA.
- 2ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, MA.
- 3Sidney Kimmel Comprehensive Cancer Center at Jefferson Health, Philadelphia, PA.
- 4Department of Medical Oncology, Sidney Kimmel Medical College, Philadelphia, PA.
- 5The Ohio State University Comprehensive Cancer Center, Columbus, OH.
- 6University of North Carolina at Chapel Hill, Chapel Hill, NC.
Förderung
- NCI NIH HHS
Zitieren
APA
Pearson, L. K., Zheng, Y., Nikita, N., Lu-Yao, G., Presley, C. J., Wagner, L. I., Simon, M. A., & Dotan, E. (2025). Unveiling Factors Associated With Older Adult Accrual to Cancer Clinical Trials: Lessons From the ECOG-ACRIN Experience. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2025.7076
Vancouver
Pearson LK, Zheng Y, Nikita N, Lu-Yao G, Presley CJ, Wagner LI, et al. Unveiling Factors Associated With Older Adult Accrual to Cancer Clinical Trials: Lessons From the ECOG-ACRIN Experience. Journal of the National Comprehensive Cancer Network. 2025. doi:10.6004/jnccn.2025.7076
BibTeX
@article{Pearson2025,
author = {Pearson, Laurie K and Zheng, Yue and Nikita, Nikita and Lu-Yao, Grace and Presley, Carolyn J and Wagner, Lynne I and Simon, Melissa A and Dotan, Efrat},
title = {Unveiling Factors Associated With Older Adult Accrual to Cancer Clinical Trials: Lessons From the ECOG-ACRIN Experience},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2025},
doi = {10.6004/jnccn.2025.7076}
}
EUVIMED